TI
FHTX icon

Trexquant Investment’s Foghorn Therapeutics FHTX Stock Holding History

Trexquant Investment’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144K Buy
+30,111
New +$165K ﹤0.01% 1687
2025
Q4 		– Sell
-22,025
Closed -$108K – 1692
2025
Q3 		$108K Buy
+22,025
New +$117K ﹤0.01% 1535
2025
Q2 		– Sell
-35,585
Closed -$130K – 1639
2025
Q1 		$130K Sell
35,585
-26,013
-42% -$119K ﹤0.01% 1492
2024
Q4 		$291K Buy
61,598
+994
+2% +$7.24K ﹤0.01% 1411
2024
Q3 		$564K Buy
+60,604
New +$439K 0.01% 1220
2023
Q2 		– Sell
-14,283
Closed -$88.6K – 1543
2023
Q1 		$88.6K Sell
14,283
-21,973
-61% -$144K ﹤0.01% 1380
2022
Q4 		$231K Buy
36,256
+14,059
+63% +$106K 0.01% 1192
2022
Q3 		$190K Buy
+22,197
New +$286K 0.01% 1203

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Trexquant Investment's FHTX Position: Q1 2026 in Review

Trexquant Investment opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 30,111 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #1687 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in FHTX as recently as Q3 2025.

Trexquant Investment first reported a position in FHTX in Q3 2022 and has held it in 8 quarters since. The position peaked at $564K in Q3 2024. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Trexquant Investment held 30,111 shares of Foghorn Therapeutics worth $144K as of Q1 2026.
  • Foghorn Therapeutics was a new Trexquant Investment position in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1687 holding.
  • Trexquant Investment first reported a position in Foghorn Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • Trexquant Investment's Foghorn Therapeutics position peaked at $564K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.